Author: UW CTI

According to a recent study on artificial intelligence (AI) by JAMA Cardiology, model applications show promise for improving the accuracy and speed of event classification in multicenter clinical trials. The study examined the potential for natural language processing (NLP) models to accurately classify heart failure (HF)...

DeSantes, a UW Carbone Cancer Center researcher and Medical Director for the Pediatric Bone Marrow Transplant and Cell Therapy program, said this phase I-II clinical trial uses a variation of an existing immunotherapy drug as part of a combination therapy for neuroblastoma patients who have advanced...

The COVID-19 pandemic opened the door for some significant and noteworthy changes to the way our industry could accomplish clinical trials with a forced mandate to decentralize access and services for the continuation of studies....

Bonnie Le Blanc’s faith has been a source of comfort and strength as she has endured life’s hardships, including two cancer diagnoses in the past eight years. Le Blanc was curatively treated for breast cancer and now is committed to fighting her stage IV melanoma...

A vast majority of people still do not understand the process of drug development unless clinical trials are the only treatment option left, says Richard Torbett, chief executive at the Association of the British Pharmaceutical Industry (ABPI)....